The College is updating our MTI Scheme Appointment fee structure in order to offer a greater package of support and ultimately improve the quality of MTI Participant’s time in training within the UK.
The College is updating our MTI Scheme Appointment fee structure in order to offer a greater package of support and ultimately improve the quality of MTI Participant’s time in training within the UK.
As you will be aware, the College has not previously charged the hosting Trust for MTI placements, however, with participant numbers rising every year there is the increased responsibility to support the quality of training, education and assurance processes to ensure that this period of training and experience in the UK is as useful as possible for overseas doctors, as well the growing need to sufficiently cover the costs of administrative time spent processing applications and administering the scheme.
+ Fee Structure
The fee will be £2,500 per doctor and will be charged to the Trust at the point when sponsorship is confirmed.
This fee structure will be implemented from August 2nd 2021, any new applications received after that date will be subject to this fee.
The implementation of this fee will ensure that all EM MTI Participants will receive the following:
This change will bring the RCEM scheme in line with MTI Schemes provided by other Medical Royal Colleges and we hope you appreciate that the increased investment into the scheme will ultimately help towards its primary purpose of contributing to the improvement of the quality of healthcare in developing countries by allowing a small number of overseas doctors to access a limited period of training and development in the NHS, before returning to their home countries where their patients, colleagues can be of benefit from the skills and experience they have obtained in the UK.
Due to the impact of COVID-19 on Specialty Training, the Academy of Medical Royal Colleges have released the statement found here
In the light of the situation, the English Deans have made the following statement which will be on their website:
“English Deans fully support and value the MTI programme and will continue to make decisions on placements based on the published principles and national standards (AoMRC MTI Standards 2018 )
This includes ensuring that UK trainees/trainees on HEE programmes will not be disadvantaged.
In continuing this approach, Deans, together with all stakeholders and applicants, are mindful of the current additional curriculum pressures for UK trainees as a result of the pandemic. It is hoped that any impact on incoming MTI trainees affecting some specific specialities in specific geographical areas will be temporary.
The Academy of Medical Royal Colleges has made a statement on how best to manage the current temporary situation.”
The primary purpose of the MTI is to contribute to improving the quality of healthcare in developing countries. The main intention of the scheme is to provide doctors from developing countries with a period of training and development in the NHS before returning to their home countries where their patients and colleagues can benefit from the skills and experience they have obtained in the UK.
A mechanism was introduced in January 2017, which demonstrates support for the Department for Health’s main focus, which is for doctors from the DFiD 28 and Lower Income Lower Middle Income countries to benefit from the scheme and, therefore priority should be given to developing healthcare systems.
The new criteria reflects the principles and intent of the scheme and it has been agreed that the following priority list be used.
The current prioritising system has been working effectively but has had unintended consequences for applicants not from DfID priority and LI&LMI countries. These applications were considered at the end of each month and CoS’s allocated if there was available capacity from the monthly quota once the allocations to DfID priority and LI&LMI countries had been made. However, the overall volume of applications received, has resulted in a growing proportion of these applications being rolled over for consideration at the end of the following month.
The consequence was that these applicants could find themselves waiting up to several months to confirm an MTI placement. This delay and uncertainty understandably caused real problems for individual applicants, employers, Colleges and Deaneries. The Department of Health, Health Education England and the Academy of Medical Royal Colleges all believe that position was unsustainable and unfair to applicants. For the sake of transparency it was felt better to explicitly state that these applicants can have no guarantee or expectation of receiving a CoS, although they will not be barred from making applications.
Applicants from countries not considered DfID priority or LI&LMI countries may apply at their own risk. If there is any remaining capacity at the end of each month having processed all applications from DfID priority and LI&LMI countries, other applicants will be awarded a CoS taken in order of the receipt of their applications.